首页 > 最新文献

Bjog-An International Journal of Obstetrics and Gynaecology最新文献

英文 中文
Comparing the psychological outcomes of donor and non-donor conceived people: A systematic review 比较捐献者和非捐献者受孕者的心理结果:系统回顾
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-27 DOI: 10.1111/1471-0528.17892
Charlotte Talbot, Nathan Hodson, Joanne Rose, Susan Bewley
<div> <section> <h3> Background</h3> <p>Over 70 000 donor-conceived (DC) people have been born in the UK since 1991. Little is known about their long-term psychological outcomes and no systematic review has assessed these.</p> </section> <section> <h3> Objectives</h3> <p>To conduct a systematic review of the psychological experiences of DC people through childhood and adulthood (Prospero: CRD42021257863).</p> </section> <section> <h3> Search strategy</h3> <p>Searches of Cumulative Index to Nursing and Allied Health Literature (CINHAL), the Excerpta Medica database (Embase), MEDLINE® and PsycINFO, conducted on 4 January 2024.</p> </section> <section> <h3> Selection criteria</h3> <p>Quantitative and qualitative studies were included if: there were five or more participants; they were peer reviewed; and any DC psychological outcomes were assessed. No limits on date, language or country were applied.</p> </section> <section> <h3> Data collection and analysis</h3> <p>Double screening, selection, data extraction and quality assessment were performed, using Joanna Briggs Institute (JBI) scoring.</p> </section> <section> <h3> Main results</h3> <p>Fifty studies (with 4666 DC participants), mostly from high-income anglophone countries, with heterogeneity of design, populations and outcome measures, were included. Of 19 comparative studies, 14 found no difference in outcomes between DC and non-DC people, ten found better outcomes (in health, well-being, self-esteem and emotional warmth) and six found worse outcomes (increased autism spectrum disorder and attention deficit hyperactivity disorder, addiction issues, mental illness, disruptive behaviour and identity problems). Qualitative data revealed common themes relating to identity formation, mistrust and concerns regarding genetic heritage. The evidence regarding adulthood outcomes was very limited.</p> </section> <section> <h3> Conclusions</h3> <p>The research on DC individuals presents a nuanced picture, with most studies suggesting comparable or improved outcomes in terms of well-being and relationships, but with a notable minority indicating higher rates of mental health and identity struggles. Qualitative findings underscore common negative experiences, whereas the early disclosure of DC status appears
背景自 1991 年以来,已有 7 万多名捐精受孕者在英国出生。对他们的长期心理结果知之甚少,也没有系统性的综述对这些结果进行评估。检索策略于 2024 年 1 月 4 日检索了《护理与专职医疗文献累积索引》(CINHAL)、Excerpta Medica 数据库(Embase)、MEDLINE® 和 PsycINFO。筛选标准纳入定性和定量研究,条件是:有五名或五名以上参与者;经过同行评审;评估了任何 DC 心理结果。数据收集和分析采用乔安娜-布里格斯研究所(JBI)评分法进行双重筛选、选择、数据提取和质量评估。主要结果纳入了 50 项研究(共有 4666 名 DC 参与者),这些研究大多来自高收入英语国家,在设计、人群和结果测量方面存在异质性。在 19 项比较研究中,有 14 项研究发现幼儿保育和非幼儿保育的结果没有差异,10 项研究发现了更好的结果(在健康、幸福、自尊和情感温暖方面),6 项研究发现了更差的结果(自闭症谱系障碍和注意缺陷多动障碍、成瘾问题、精神疾病、破坏性行为和身份问题增加)。定性数据揭示了与身份形成、不信任和对遗传基因的担忧有关的共同主题。有关成年后结果的证据非常有限。结论 关于特发性残疾个体的研究呈现出一种细致入微的情况,大多数研究表明,他们在幸福感和人际关系方面的结果相当或有所改善,但也有明显的少数研究表明,心理健康和身份认同方面的问题发生率较高。定性研究结果强调了常见的负面经历,而及早披露残疾人士身份似乎有利于心理健康。
{"title":"Comparing the psychological outcomes of donor and non-donor conceived people: A systematic review","authors":"Charlotte Talbot,&nbsp;Nathan Hodson,&nbsp;Joanne Rose,&nbsp;Susan Bewley","doi":"10.1111/1471-0528.17892","DOIUrl":"10.1111/1471-0528.17892","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Over 70 000 donor-conceived (DC) people have been born in the UK since 1991. Little is known about their long-term psychological outcomes and no systematic review has assessed these.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objectives&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To conduct a systematic review of the psychological experiences of DC people through childhood and adulthood (Prospero: CRD42021257863).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Search strategy&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Searches of Cumulative Index to Nursing and Allied Health Literature (CINHAL), the Excerpta Medica database (Embase), MEDLINE® and PsycINFO, conducted on 4 January 2024.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Selection criteria&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Quantitative and qualitative studies were included if: there were five or more participants; they were peer reviewed; and any DC psychological outcomes were assessed. No limits on date, language or country were applied.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Data collection and analysis&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Double screening, selection, data extraction and quality assessment were performed, using Joanna Briggs Institute (JBI) scoring.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Fifty studies (with 4666 DC participants), mostly from high-income anglophone countries, with heterogeneity of design, populations and outcome measures, were included. Of 19 comparative studies, 14 found no difference in outcomes between DC and non-DC people, ten found better outcomes (in health, well-being, self-esteem and emotional warmth) and six found worse outcomes (increased autism spectrum disorder and attention deficit hyperactivity disorder, addiction issues, mental illness, disruptive behaviour and identity problems). Qualitative data revealed common themes relating to identity formation, mistrust and concerns regarding genetic heritage. The evidence regarding adulthood outcomes was very limited.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The research on DC individuals presents a nuanced picture, with most studies suggesting comparable or improved outcomes in terms of well-being and relationships, but with a notable minority indicating higher rates of mental health and identity struggles. Qualitative findings underscore common negative experiences, whereas the early disclosure of DC status appears","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"131 13","pages":"1747-1759"},"PeriodicalIF":4.7,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17892","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141462202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vascular Ehlers-Danlos syndrome and pregnancy: A systematic review 血管性埃勒斯-丹洛斯综合征与妊娠:系统综述。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-26 DOI: 10.1111/1471-0528.17893
Théo Haem, Betty Benson, Amandine Dernoncourt, Jean Gondry, Jean Schmidt, Arthur Foulon

Background

Vascular Ehlers-Danlos syndrome (vEDS) is a hereditary connective tissue disorder associated with an elevated risk of vascular, uterine and digestive complications. Managing pregnancy in this context can be a challenge.

Objectives

To systematically review the literature data on the complications in pregnancy associated with vEDS.

Search strategy

We searched the Pubmed Medline and Embase databases for articles using the following terms “vascular Ehlers-Danlos syndrome” or “vEDS” AND “pregnancy”.

Selection criteria

Women with vEDS.

Data collection and analysis

We searched the PubMed® MEDLINE® database for publications evaluating obstetric outcomes in women with vEDS.

Main results

A total of 121 publications were screened, with six (accounting for 412 pregnancies) included in our review. Of the women included in this sample, 30% were infertile. The miscarriage rate was 13.8% (57/412) and 8.8% of the live births were premature. Obstetric anal sphincter injuries occurred in 11.3% (23/203) of the deliveries. The maternal mortality rate per pregnancy was 5.7%.

Conclusions

Women with vEDS present an elevated risk of uterine rupture, vascular events, digestive events and death during pregnancy. Women appear to be most at risk during the peripartum period; to avoid expulsive efforts, a caesarean section should be scheduled at 37 weeks of gestation.

背景:血管性埃勒斯-丹洛斯综合征(vEDS血管性埃勒斯-丹洛斯综合征(vEDS)是一种遗传性结缔组织疾病,与血管、子宫和消化系统并发症的高风险有关。在这种情况下管理妊娠是一项挑战:系统回顾与 vEDS 相关的妊娠并发症的文献数据:我们在 Pubmed Medline 和 Embase 数据库中以 "血管性 Ehlers-Danlos 综合征 "或 "vEDS "和 "妊娠 "为关键词检索文章:数据收集与分析:我们在PubMed® MEDLINE®数据库中检索了评估vEDS女性产科结果的出版物:主要结果:共筛选出 121 篇出版物,其中 6 篇(涉及 412 例妊娠)被纳入我们的综述。在这些样本中,30%的女性未育。流产率为13.8%(57/412),8.8%的活产为早产。产科肛门括约肌损伤发生率为 11.3%(23/203)。每次妊娠的产妇死亡率为 5.7%:结论:患有vEDS的妇女在怀孕期间发生子宫破裂、血管事件、消化系统事件和死亡的风险较高。妇女在围产期面临的风险似乎最大;为避免用力挤压,应在妊娠 37 周时安排剖腹产。
{"title":"Vascular Ehlers-Danlos syndrome and pregnancy: A systematic review","authors":"Théo Haem,&nbsp;Betty Benson,&nbsp;Amandine Dernoncourt,&nbsp;Jean Gondry,&nbsp;Jean Schmidt,&nbsp;Arthur Foulon","doi":"10.1111/1471-0528.17893","DOIUrl":"10.1111/1471-0528.17893","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Vascular Ehlers-Danlos syndrome (vEDS) is a hereditary connective tissue disorder associated with an elevated risk of vascular, uterine and digestive complications. Managing pregnancy in this context can be a challenge.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>To systematically review the literature data on the complications in pregnancy associated with vEDS.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Search strategy</h3>\u0000 \u0000 <p>We searched the Pubmed Medline and Embase databases for articles using the following terms “vascular Ehlers-Danlos syndrome” or “vEDS” AND “pregnancy”.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Selection criteria</h3>\u0000 \u0000 <p>Women with vEDS.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data collection and analysis</h3>\u0000 \u0000 <p>We searched the PubMed® MEDLINE® database for publications evaluating obstetric outcomes in women with vEDS.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main results</h3>\u0000 \u0000 <p>A total of 121 publications were screened, with six (accounting for 412 pregnancies) included in our review. Of the women included in this sample, 30% were infertile. The miscarriage rate was 13.8% (57/412) and 8.8% of the live births were premature. Obstetric anal sphincter injuries occurred in 11.3% (23/203) of the deliveries. The maternal mortality rate per pregnancy was 5.7%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Women with vEDS present an elevated risk of uterine rupture, vascular events, digestive events and death during pregnancy. Women appear to be most at risk during the peripartum period; to avoid expulsive efforts, a caesarean section should be scheduled at 37 weeks of gestation.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"131 12","pages":"1620-1629"},"PeriodicalIF":4.7,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17893","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal death by cancer in pregnancy: A descriptive study of the International Network on Cancer, Infertility and Pregnancy 孕产妇死于妊娠期癌症:国际癌症、不孕症和妊娠网络的描述性研究。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-25 DOI: 10.1111/1471-0528.17894
Joosje H. Heimovaara, Evangeline A. Huis in ’t Veld, Christianne A. R. Lok, Alvaro Cabrera Garcia, Michael J. Halaska, Ingrid Boere, Mina Mhallem Gziri, Robert Fruscio, Rebecca C. Painter, Elyce Cardonick, Marry M. van den Heuvel-Eibrink, B. Masturzo, Kristel Van Calsteren, Lia van Zuylen, Frederic Amant, for the International Network on Cancer Infertility and Pregnancy

Objective

To characterise pregnant women diagnosed with primary or recurrent cancer who died during pregnancy, during delivery or within 1 year postpartum.

Design

A descriptive study.

Setting

The registry of the International Network on Cancer, Infertility and Pregnancy (INCIP).

Population

Women diagnosed with cancer during pregnancy between 2000 and 2022.

Methods

Using the INCIP registry database, we compared the characteristics of all women with cancer who died during pregnancy, delivery or within 1 year postpartum with those of all women with cancer who survived the first year postpartum.

Main Outcome Measures

Maternal and tumour characteristics and obstetrical and neonatal outcomes.

Results

Of the 2359 women registered in INCIP, there were 131 cases (5.6%) of maternal mortality. Lung cancer (9/14, 64.3% of all registered women with lung cancer), gastro-oesophageal cancer (13/21, 61.9%) and acute leukaemia (17/105, 16.2%) had the highest rates of maternal mortality. Maternal mortality was associated with fewer live births compared with the control group without maternal mortality (99/131, 75.6%, vs 1952/2163, 90.0%; P < 0.001), more elective caesarean sections (64/104, 60.4%, vs 756/1836, 41.2%; P < 0.001) and a lower gestational age at (induced) delivery (34.0 vs 37.1 weeks; P < 0.001), resulting in more preterm births.

Conclusions

Maternal mortality occurred in 5.6% of cancer-in-pregnancy cases and is associated with adverse perinatal outcomes.

目的描述确诊为原发性或复发性癌症的孕妇在怀孕期间、分娩时或产后 1 年内死亡的情况:描述性研究:国际癌症、不孕症和妊娠网络(INCIP)登记处:方法:使用 INCIP 登记数据库:利用 INCIP 登记数据库,我们比较了所有在怀孕、分娩期间或产后 1 年内死亡的癌症妇女与所有在产后 1 年内存活的癌症妇女的特征:产妇和肿瘤特征以及产科和新生儿结局:在 INCIP 登记的 2359 名妇女中,有 131 例(5.6%)产妇死亡。肺癌(9/14,占所有登记肺癌妇女的 64.3%)、胃食道癌(13/21,61.9%)和急性白血病(17/105,16.2%)的产妇死亡率最高。与没有孕产妇死亡的对照组相比,孕产妇死亡与活产数减少有关(99/131,75.6%,vs 1952/2163,90.0%;P 结论:与没有孕产妇死亡的对照组相比,孕产妇死亡与活产数减少有关:5.6%的妊娠期癌症病例出现孕产妇死亡,并与不良围产期结果有关。
{"title":"Maternal death by cancer in pregnancy: A descriptive study of the International Network on Cancer, Infertility and Pregnancy","authors":"Joosje H. Heimovaara,&nbsp;Evangeline A. Huis in ’t Veld,&nbsp;Christianne A. R. Lok,&nbsp;Alvaro Cabrera Garcia,&nbsp;Michael J. Halaska,&nbsp;Ingrid Boere,&nbsp;Mina Mhallem Gziri,&nbsp;Robert Fruscio,&nbsp;Rebecca C. Painter,&nbsp;Elyce Cardonick,&nbsp;Marry M. van den Heuvel-Eibrink,&nbsp;B. Masturzo,&nbsp;Kristel Van Calsteren,&nbsp;Lia van Zuylen,&nbsp;Frederic Amant,&nbsp;for the International Network on Cancer Infertility and Pregnancy","doi":"10.1111/1471-0528.17894","DOIUrl":"10.1111/1471-0528.17894","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To characterise pregnant women diagnosed with primary or recurrent cancer who died during pregnancy, during delivery or within 1 year postpartum.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>A descriptive study.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Setting</h3>\u0000 \u0000 <p>The registry of the International Network on Cancer, Infertility and Pregnancy (INCIP).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Population</h3>\u0000 \u0000 <p>Women diagnosed with cancer during pregnancy between 2000 and 2022.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Using the INCIP registry database, we compared the characteristics of all women with cancer who died during pregnancy, delivery or within 1 year postpartum with those of all women with cancer who survived the first year postpartum.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main Outcome Measures</h3>\u0000 \u0000 <p>Maternal and tumour characteristics and obstetrical and neonatal outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of the 2359 women registered in INCIP, there were 131 cases (5.6%) of maternal mortality. Lung cancer (9/14, 64.3% of all registered women with lung cancer), gastro-oesophageal cancer (13/21, 61.9%) and acute leukaemia (17/105, 16.2%) had the highest rates of maternal mortality. Maternal mortality was associated with fewer live births compared with the control group without maternal mortality (99/131, 75.6%, vs 1952/2163, 90.0%; <i>P</i> &lt; 0.001), more elective caesarean sections (64/104, 60.4%, vs 756/1836, 41.2%; <i>P</i> &lt; 0.001) and a lower gestational age at (induced) delivery (34.0 vs 37.1 weeks; <i>P</i> &lt; 0.001), resulting in more preterm births.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Maternal mortality occurred in 5.6% of cancer-in-pregnancy cases and is associated with adverse perinatal outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"131 12","pages":"1694-1704"},"PeriodicalIF":4.7,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence distributions, risk factors and trends of vaginal cancer: A global population-based study 阴道癌的发病率分布、风险因素和趋势:全球人口研究。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-25 DOI: 10.1111/1471-0528.17887
Junjie Huang, Sze Chai Chan, Wing Sze Pang, Fung Yu Mak, Yat Ching Fung, Veeleah Lok, Lin Zhang, Xu Lin, Don Eliseo Lucero-Prisno III, Wanghong Xu, Zhi-Jie Zheng, Edmar Elcarte, Mellissa Withers, Martin C. S. Wong, the NCD Global Health Research Group, Association of Pacific Rim Universities (APRU)
<div> <section> <h3> Objective</h3> <p>This study aimed to investigate the incidence, risk factors and trends for vaginal cancer.</p> </section> <section> <h3> Design</h3> <p>Retrospective observational design.</p> </section> <section> <h3> Setting</h3> <p>Data were collected from multiple sources, including the Global Cancer Observatory, Cancer Incidence in Five Continents Plus, Global Burden of Disease, World Bank and the United Nations.</p> </section> <section> <h3> Population</h3> <p>Individuals diagnosed with vaginal cancer.</p> </section> <section> <h3> Methods</h3> <p>The study collected data on vaginal cancer from the specified sources. The age-standardised rate (ASR) of vaginal cancer was calculated for different regions and age groups. Multivariable and univariable linear regression analyses were performed to examine the associations between risk factors and the incidence of vaginal cancer. Trend analysis was conducted using joinpoint regression analysis, and the average annual percentage change (AAPC) was calculated to quantify the temporal trend.</p> </section> <section> <h3> Main Outcome Measures</h3> <p>The main outcome measures of the study were the incidence of vaginal cancer, risk factors associated with the disease and the trend of its incidence over time.</p> </section> <section> <h3> Results</h3> <p>There were 17 908 newly reported cases of vaginal cancer (ASR = 0.36, 95% CI 0.30–0.44) in 2020, with the highest ASRs reported in South–Central Asia and Southern Africa. Risk factors associated with a higher incidence of vaginal cancer included a higher prevalence of unsafe sex and human immunodeficiency virus (HIV) infection. The temporal trend showed an overall rising incidence globally, with Iceland (AAPC = 29.56, 95% CI 12.12–49.71), Chile (AAPC = 22.83, 95% CI 13.20–33.27), Bahrain (AAPC = 22.05, 95% CI 10.83–34.40) and the UK (AAPC = 1.40, 95% CI 0.41–2.39) demonstrating the most significant rising trends.</p> </section> <section> <h3> Conclusions</h3> <p>The significant regional disparities and risk factors associated with vaginal cancer underscore the necessity for targeted interventions and education, particularly in region
目的:本研究旨在调查阴道癌的发病率、风险因素和发展趋势:本研究旨在调查阴道癌的发病率、风险因素和发展趋势:设计:回顾性观察设计:数据来自多个来源,包括全球癌症观察站、五大洲癌症发病率+、全球疾病负担、世界银行和联合国:方法:收集阴道癌数据:研究从指定来源收集阴道癌数据。计算了不同地区和年龄组的阴道癌年龄标准化比率(ASR)。对风险因素与阴道癌发病率之间的关系进行了多变量和单变量线性回归分析。使用连接点回归分析法进行趋势分析,并计算年平均百分比变化(AAPC),以量化时间趋势:研究的主要结果是阴道癌的发病率、与该疾病相关的风险因素以及发病率的时间趋势:2020年新报告的阴道癌病例为17 908例(ASR=0.36,95% CI 0.30-0.44),中南亚和南部非洲的ASR最高。与阴道癌发病率较高相关的风险因素包括不安全性行为和人体免疫缺陷病毒(HIV)感染率较高。时间趋势显示,全球发病率总体呈上升趋势,其中冰岛(AAPC = 29.56,95% CI 12.12-49.71)、智利(AAPC = 22.83,95% CI 13.20-33.27)、巴林(AAPC = 22.05,95% CI 10.83-34.40)和英国(AAPC = 1.40,95% CI 0.41-2.39)的上升趋势最为显著:与阴道癌相关的重大地区差异和风险因素强调了有针对性干预和教育的必要性,尤其是在人类发展指数(HDI)较低和人类乳头瘤病毒(HPV)感染率较高的地区。发病率上升的趋势突出表明,有必要提高人类乳头瘤病毒疫苗接种率,以预防阴道癌的发生。
{"title":"Incidence distributions, risk factors and trends of vaginal cancer: A global population-based study","authors":"Junjie Huang,&nbsp;Sze Chai Chan,&nbsp;Wing Sze Pang,&nbsp;Fung Yu Mak,&nbsp;Yat Ching Fung,&nbsp;Veeleah Lok,&nbsp;Lin Zhang,&nbsp;Xu Lin,&nbsp;Don Eliseo Lucero-Prisno III,&nbsp;Wanghong Xu,&nbsp;Zhi-Jie Zheng,&nbsp;Edmar Elcarte,&nbsp;Mellissa Withers,&nbsp;Martin C. S. Wong,&nbsp;the NCD Global Health Research Group, Association of Pacific Rim Universities (APRU)","doi":"10.1111/1471-0528.17887","DOIUrl":"10.1111/1471-0528.17887","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;This study aimed to investigate the incidence, risk factors and trends for vaginal cancer.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Retrospective observational design.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Data were collected from multiple sources, including the Global Cancer Observatory, Cancer Incidence in Five Continents Plus, Global Burden of Disease, World Bank and the United Nations.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Population&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Individuals diagnosed with vaginal cancer.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The study collected data on vaginal cancer from the specified sources. The age-standardised rate (ASR) of vaginal cancer was calculated for different regions and age groups. Multivariable and univariable linear regression analyses were performed to examine the associations between risk factors and the incidence of vaginal cancer. Trend analysis was conducted using joinpoint regression analysis, and the average annual percentage change (AAPC) was calculated to quantify the temporal trend.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main Outcome Measures&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The main outcome measures of the study were the incidence of vaginal cancer, risk factors associated with the disease and the trend of its incidence over time.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;There were 17 908 newly reported cases of vaginal cancer (ASR = 0.36, 95% CI 0.30–0.44) in 2020, with the highest ASRs reported in South–Central Asia and Southern Africa. Risk factors associated with a higher incidence of vaginal cancer included a higher prevalence of unsafe sex and human immunodeficiency virus (HIV) infection. The temporal trend showed an overall rising incidence globally, with Iceland (AAPC = 29.56, 95% CI 12.12–49.71), Chile (AAPC = 22.83, 95% CI 13.20–33.27), Bahrain (AAPC = 22.05, 95% CI 10.83–34.40) and the UK (AAPC = 1.40, 95% CI 0.41–2.39) demonstrating the most significant rising trends.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The significant regional disparities and risk factors associated with vaginal cancer underscore the necessity for targeted interventions and education, particularly in region","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"131 12","pages":"1660-1672"},"PeriodicalIF":4.7,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17887","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial 宫内接受西地那非治疗的儿童 2 岁时的神经发育结果:STRIDER随机对照试验。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-25 DOI: 10.1111/1471-0528.17888
Andrew Sharp, Christine Cornforth, Richard Jackson, Jane Harrold, Mark A. Turner, Louise C. Kenny, Philip N. Baker, Edward D. Johnstone, Asma Khalil, Peter von Dadelszen, Aris T. Papageorghiou, Zarko Alfirevic, Brigitte Vollmer, the STRIDER group
<div> <section> <h3> Objective</h3> <p>Severe early-onset fetal growth restriction (FGR) causes stillbirth, neonatal death and neurodevelopmental impairment. Poor maternal spiral artery remodelling maintains vasoactive responsiveness but is susceptible to treatment with sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, which may improve perinatal outcomes.</p> </section> <section> <h3> Design</h3> <p>Superiority, double-blind randomised controlled trial.</p> </section> <section> <h3> Setting</h3> <p>A total of 20 UK fetal medicine units.</p> </section> <section> <h3> Population</h3> <p>Pregnancies affected by FGR, defined as an abdominal circumference below the tenth centile with absent end-diastolic flow in the umbilical artery between 22<sup>+0</sup> and 29<sup>+6</sup> weeks of gestation.</p> </section> <section> <h3> Methods</h3> <p>Treatment with sildenafil (25 mg three times/day) or placebo until delivery or 32 weeks of gestation.</p> </section> <section> <h3> Main outcome measures</h3> <p>All infants alive at hospital discharge were assessed for cardiovascular function and cognitive, speech/language and neuromotor impairment at 2 years of age. The primary outcome was survival without cerebral palsy or neurosensory impairment, or a Bayley-III composite score of >85.</p> </section> <section> <h3> Results</h3> <p>In total, 135 women were randomised between November 2014 and July 2016 (70 to sildenafil and 65 to placebo). We previously published that there was no improvement in time to delivery or perinatal outcomes with sildenafil. In all, 75 babies (55.5%) were discharged alive, with 61 infants eligible for follow-up (32 sildenafil and 29 placebo). One infant died (placebo), three mothers declined and ten mothers were uncontactable. There was no difference in neurodevelopment or blood pressure following treatment with sildenafil. Infants who received sildenafil had a larger head circumference at 2 years of age (median difference 49.2 cm, IQR 46.4–50.3, vs 47.2 cm, 95% CI 44.7–48.9 cm).</p> </section> <section> <h3> Conclusions</h3> <p>Sildenafil therapy did not prolong pregnancy or improve perinatal outcomes and did not improve infan
目的:严重的早发型胎儿生长受限(FGR)会导致死胎、新生儿死亡和神经发育障碍。母体螺旋动脉重塑不良可维持血管反应性,但易受5型磷酸二酯酶(PDE5)抑制剂西地那非治疗的影响,而西地那非可改善围产期预后:优效双盲随机对照试验:人群: 受FGR影响的孕妇,FGR的定义是胎儿畸形:受 FGR 影响的孕妇,FGR 的定义是妊娠 22+0 周至 29+6 周之间腹围低于十等分,且脐动脉舒张末期血流缺失:方法:使用西地那非(25 毫克,每天三次)或安慰剂治疗,直至分娩或妊娠 32 周:对所有出院时存活的婴儿进行心血管功能以及2岁时认知、语言/言语和神经运动障碍评估。主要结果为无脑瘫或神经感觉障碍或 Bayley-III 综合评分大于 85 分的存活率:2014年11月至2016年7月期间,共有135名妇女接受了随机治疗(70名接受西地那非治疗,65名接受安慰剂治疗)。我们之前发表的研究结果表明,西地那非对分娩时间和围产期结局没有改善。共有 75 名婴儿(55.5%)存活出院,其中 61 名婴儿符合随访条件(32 名西地那非婴儿和 29 名安慰剂婴儿)。1名婴儿死亡(安慰剂),3名母亲拒绝接受治疗,10名母亲无法联系。使用西地那非治疗后,婴儿的神经发育和血压没有差异。接受西地那非治疗的婴儿在2岁时头围较大(中位数差异为49.2厘米,IQR为46.4-50.3,vs 47.2厘米,95% CI为44.7-48.9厘米):结论:西地那非治疗并不能延长FGR幸存者的妊娠期或改善围产期结局,也不能改善婴儿的神经发育。因此,西地那非不应作为治疗这种疾病的处方。
{"title":"Neurodevelopmental outcomes at 2 years in children who received sildenafil therapy in utero: The STRIDER randomised controlled trial","authors":"Andrew Sharp,&nbsp;Christine Cornforth,&nbsp;Richard Jackson,&nbsp;Jane Harrold,&nbsp;Mark A. Turner,&nbsp;Louise C. Kenny,&nbsp;Philip N. Baker,&nbsp;Edward D. Johnstone,&nbsp;Asma Khalil,&nbsp;Peter von Dadelszen,&nbsp;Aris T. Papageorghiou,&nbsp;Zarko Alfirevic,&nbsp;Brigitte Vollmer,&nbsp;the STRIDER group","doi":"10.1111/1471-0528.17888","DOIUrl":"10.1111/1471-0528.17888","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Severe early-onset fetal growth restriction (FGR) causes stillbirth, neonatal death and neurodevelopmental impairment. Poor maternal spiral artery remodelling maintains vasoactive responsiveness but is susceptible to treatment with sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, which may improve perinatal outcomes.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Superiority, double-blind randomised controlled trial.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A total of 20 UK fetal medicine units.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Population&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Pregnancies affected by FGR, defined as an abdominal circumference below the tenth centile with absent end-diastolic flow in the umbilical artery between 22&lt;sup&gt;+0&lt;/sup&gt; and 29&lt;sup&gt;+6&lt;/sup&gt; weeks of gestation.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Treatment with sildenafil (25 mg three times/day) or placebo until delivery or 32 weeks of gestation.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main outcome measures&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;All infants alive at hospital discharge were assessed for cardiovascular function and cognitive, speech/language and neuromotor impairment at 2 years of age. The primary outcome was survival without cerebral palsy or neurosensory impairment, or a Bayley-III composite score of &gt;85.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;In total, 135 women were randomised between November 2014 and July 2016 (70 to sildenafil and 65 to placebo). We previously published that there was no improvement in time to delivery or perinatal outcomes with sildenafil. In all, 75 babies (55.5%) were discharged alive, with 61 infants eligible for follow-up (32 sildenafil and 29 placebo). One infant died (placebo), three mothers declined and ten mothers were uncontactable. There was no difference in neurodevelopment or blood pressure following treatment with sildenafil. Infants who received sildenafil had a larger head circumference at 2 years of age (median difference 49.2 cm, IQR 46.4–50.3, vs 47.2 cm, 95% CI 44.7–48.9 cm).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Sildenafil therapy did not prolong pregnancy or improve perinatal outcomes and did not improve infan","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"131 12","pages":"1673-1683"},"PeriodicalIF":4.7,"publicationDate":"2024-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17888","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reconstructive surgery for women with female genital mutilation: A scoping review 女性外阴残割妇女的整形手术:范围审查
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-24 DOI: 10.1111/1471-0528.17886
Aurora Almadori, Stefania Palmieri, Christie Coho, Catrin Evans, Soheir Elneil, Juliet Albert

Background

Female genital mutilation (FGM) is a global public health concern. However, reconstructive surgery remains unavailable in many countries.

Objectives

This scoping review, guided by Joanna Briggs Institute (JBI) principles, explores indications, referral routes, eligibility, care pathways and clinical outcomes of reconstructive surgery for FGM.

Search strategy

Medical Subject Headings (MeSH) terms and subject headings were searched in EMBASE, MEDLINE, SCOPUS, Web of Science and publicly available trial registers.

Selection criteria

Any primary experimental and quasi-experimental study addressing reconstructive surgery for FGM, and its impact on women, published before June 2023.

Data collection and analysis

After removing duplicates from the search results, titles and abstracts were screened and data were extracted. Disagreements were resolved through panel discussion. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) flow diagram depicts the search results and inclusion process.

Main results

A total of 40 studies were included. Multidisciplinary teams were involved in 40% (16/40) of the studies, and psychosexual counselling was offered in 37.5% (15/40) of studies. Clitoral reconstruction using Foldes’ technique was predominant (95%, 38/40). A total of 7274 women underwent some form of reconstruction. Post-surgery improvement was reported in 94% of the cases (6858/7274). The complication rate was 3% (207/7722 women with reconstruction).

Conclusions

Further research and clinical trials are needed. Although the outcomes suggest improved sexual function and quality of life post-surgery, the evidence remains limited. Advocating surgical reconstruction for survivors of FGM is vital for addressing health disparities and potential cost-effectiveness.

切割女性生殖器(FGM)是一个全球性的公共卫生问题。然而,许多国家仍然无法提供整形手术。
{"title":"Reconstructive surgery for women with female genital mutilation: A scoping review","authors":"Aurora Almadori,&nbsp;Stefania Palmieri,&nbsp;Christie Coho,&nbsp;Catrin Evans,&nbsp;Soheir Elneil,&nbsp;Juliet Albert","doi":"10.1111/1471-0528.17886","DOIUrl":"10.1111/1471-0528.17886","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Female genital mutilation (FGM) is a global public health concern. However, reconstructive surgery remains unavailable in many countries.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>This scoping review, guided by Joanna Briggs Institute (JBI) principles, explores indications, referral routes, eligibility, care pathways and clinical outcomes of reconstructive surgery for FGM.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Search strategy</h3>\u0000 \u0000 <p>Medical Subject Headings (MeSH) terms and subject headings were searched in EMBASE, MEDLINE, SCOPUS, Web of Science and publicly available trial registers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Selection criteria</h3>\u0000 \u0000 <p>Any primary experimental and quasi-experimental study addressing reconstructive surgery for FGM, and its impact on women, published before June 2023.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Data collection and analysis</h3>\u0000 \u0000 <p>After removing duplicates from the search results, titles and abstracts were screened and data were extracted. Disagreements were resolved through panel discussion. The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) flow diagram depicts the search results and inclusion process.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Main results</h3>\u0000 \u0000 <p>A total of 40 studies were included. Multidisciplinary teams were involved in 40% (16/40) of the studies, and psychosexual counselling was offered in 37.5% (15/40) of studies. Clitoral reconstruction using Foldes’ technique was predominant (95%, 38/40). A total of 7274 women underwent some form of reconstruction. Post-surgery improvement was reported in 94% of the cases (6858/7274). The complication rate was 3% (207/7722 women with reconstruction).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Further research and clinical trials are needed. Although the outcomes suggest improved sexual function and quality of life post-surgery, the evidence remains limited. Advocating surgical reconstruction for survivors of FGM is vital for addressing health disparities and potential cost-effectiveness.</p>\u0000 </section>\u0000 </div>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"131 12","pages":"1604-1619"},"PeriodicalIF":4.7,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17886","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141445085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute symptoms of depression and traumatic stress in men and women who terminate pregnancy after the detection of fetal anomaly: A prospective observational study. 发现胎儿畸形后终止妊娠的男性和女性的急性抑郁症状和创伤性应激反应:一项前瞻性观察研究。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-20 DOI: 10.1111/1471-0528.17884
Mona Bekkhus, Aurora Oftedal, Guttorm Haugen, Berit Mortensen, Anne Kaasen

Objective: To assess acute and long-term stress in men and women after the detection of fetal anomalies leading to pregnancy termination.

Design: Prospective observational study.

Setting: Tertiary referral centre for fetal medicine.

Population: From the initial sample of 180 pregnant women with a fetal anomaly detected by ultrasound examination, a total of 87 women terminated their pregnancy, with 72 partners included in the sample. At the time of detection, the group of women (n = 93) and their partners (n = 81) who did not terminate the pregnancy following a diagnosis were included as a comparison group.

Methods: These women and their partners were asked to complete the Edinburgh Postnatal Depression Scale (EPDS) and the Impact of Events Scale (IES) questionnaires, both at the time of initial detection and at 6 weeks after the termination of the pregnancy.

Main outcome measures: Responses to the EPDS and the IES at the time of initial detection and at 6 weeks after pregnancy termination.

Results: Women who underwent pregnancy termination reported higher symptom levels of depression, but not traumatic stress, prior to the termination than women who chose not to terminate their pregnancy. Among men, there was a difference across depression and all subscales of traumatic stress (e.g. IES intrusion: mean difference 5.31; 95% CI 2.32-8.31). Women experienced more depressive symptoms over time than men (β = 4.33, P < 0.001) and higher symptom levels on all subscales of traumatic stress (e.g. IES intrusion: β = 5.27; P < 0.001).

Conclusions: Overall, our study underscores the heightened levels of depression and traumatic stress experienced by prospective parents, particularly prior to the decision to terminate a pregnancy following the detection of a fetal anomaly. Although women generally report more pronounced symptoms, it is noteworthy that men also experience considerable traumatic stress during this challenging time.

目的评估胎儿异常导致终止妊娠后男性和女性的急性和长期压力:前瞻性观察研究:地点:胎儿医学三级转诊中心:在最初抽取的180名通过超声波检查发现胎儿异常的孕妇中,共有87名孕妇终止了妊娠,其中72名孕妇的伴侣也被纳入样本。在检测时,没有在确诊后终止妊娠的妇女(93 人)及其伴侣(81 人)被列为对比组:这些妇女及其伴侣被要求填写爱丁堡产后抑郁量表(EPDS)和事件影响量表(IES)问卷,时间分别为最初发现时和终止妊娠后 6 周:主要结果测量:最初发现时和终止妊娠后 6 周对 EPDS 和 IES 的反应:结果:与选择不终止妊娠的妇女相比,终止妊娠的妇女在终止妊娠前的抑郁症状水平较高,但创伤性应激反应水平不高。在男性中,抑郁症和创伤性应激反应的所有分量表都存在差异(如 IES 入侵:平均差异为 5.31;95% CI 为 2.32-8.31)。随着时间的推移,女性比男性出现更多的抑郁症状(β = 4.33,P 结论:随着时间的推移,女性比男性出现更多的抑郁症状:总体而言,我们的研究强调了准父母所经历的抑郁和创伤性应激水平,尤其是在发现胎儿异常后决定终止妊娠之前。虽然女性通常会有更明显的症状,但值得注意的是,男性在这一充满挑战的时期也会经历相当大的创伤性压力。
{"title":"Acute symptoms of depression and traumatic stress in men and women who terminate pregnancy after the detection of fetal anomaly: A prospective observational study.","authors":"Mona Bekkhus, Aurora Oftedal, Guttorm Haugen, Berit Mortensen, Anne Kaasen","doi":"10.1111/1471-0528.17884","DOIUrl":"10.1111/1471-0528.17884","url":null,"abstract":"<p><strong>Objective: </strong>To assess acute and long-term stress in men and women after the detection of fetal anomalies leading to pregnancy termination.</p><p><strong>Design: </strong>Prospective observational study.</p><p><strong>Setting: </strong>Tertiary referral centre for fetal medicine.</p><p><strong>Population: </strong>From the initial sample of 180 pregnant women with a fetal anomaly detected by ultrasound examination, a total of 87 women terminated their pregnancy, with 72 partners included in the sample. At the time of detection, the group of women (n = 93) and their partners (n = 81) who did not terminate the pregnancy following a diagnosis were included as a comparison group.</p><p><strong>Methods: </strong>These women and their partners were asked to complete the Edinburgh Postnatal Depression Scale (EPDS) and the Impact of Events Scale (IES) questionnaires, both at the time of initial detection and at 6 weeks after the termination of the pregnancy.</p><p><strong>Main outcome measures: </strong>Responses to the EPDS and the IES at the time of initial detection and at 6 weeks after pregnancy termination.</p><p><strong>Results: </strong>Women who underwent pregnancy termination reported higher symptom levels of depression, but not traumatic stress, prior to the termination than women who chose not to terminate their pregnancy. Among men, there was a difference across depression and all subscales of traumatic stress (e.g. IES intrusion: mean difference 5.31; 95% CI 2.32-8.31). Women experienced more depressive symptoms over time than men (β = 4.33, P < 0.001) and higher symptom levels on all subscales of traumatic stress (e.g. IES intrusion: β = 5.27; P < 0.001).</p><p><strong>Conclusions: </strong>Overall, our study underscores the heightened levels of depression and traumatic stress experienced by prospective parents, particularly prior to the decision to terminate a pregnancy following the detection of a fetal anomaly. Although women generally report more pronounced symptoms, it is noteworthy that men also experience considerable traumatic stress during this challenging time.</p>","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":4.7,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141428124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in the prevalence of maternal chronic conditions during pregnancy: A nationwide age–period–cohort analysis 孕期孕产妇慢性病患病率的变化:全国范围内的年龄段队列分析。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-20 DOI: 10.1111/1471-0528.17885
Louise Lundborg, Cande V. Ananth, K. S. Joseph, Sven Cnattingius, Neda Razaz
<div> <section> <h3> Objective</h3> <p>To estimate temporal changes in the prevalence of pre-existing chronic conditions among pregnant women in Sweden and evaluate the extent to which secular changes in maternal age, birth cohorts and obesity are associated with these trends.</p> </section> <section> <h3> Design</h3> <p>Population-based cross-sectional study.</p> </section> <section> <h3> Setting</h3> <p>Sweden, 2002–2019.</p> </section> <section> <h3> Population</h3> <p>All women (aged 15–49 years) who delivered in Sweden (2002–2019).</p> </section> <section> <h3> Methods</h3> <p>An age–period–cohort analysis was used to evaluate the effects of age, calendar periods, and birth cohorts on the observed temporal trends.</p> </section> <section> <h3> Main outcome measures</h3> <p>Pre-existing chronic conditions, including 17 disease categories of physical and psychiatric health conditions recorded within 5 years before childbirth, presented as prevalence rates and rate ratios (RRs) with 95% confidence intervals (CIs). Temporal trends were also adjusted for pre-pregnancy body mass index (BMI) and the mother's country of birth.</p> </section> <section> <h3> Results</h3> <p>The overall prevalence of at least one pre-existing chronic condition was 8.7% (147 458 of 1 703 731 women). The rates of pre-existing chronic conditions in pregnancy increased threefold between 2002–2006 and 2016–2019 (RR 2.82, 95% CI 2.77–2.87). Rates of psychiatric (RR 3.80, 95% CI 3.71–3.89), circulatory/metabolic (RR 1.62, 95% CI 1.55–1.71), autoimmune/neurological (RR 1.69, 95% CI 1.61–1.78) and other (RR 2.10, 95% CI 1.99–2.22) conditions increased substantially from 2002–2006 to 2016–2019. However, these increasing rates were less pronounced between 2012–2015 and 2016–2019. No birth cohort effect was evident for any of the pre-existing chronic conditions. Adjusting for secular changes in obesity and the mother's country of birth did not affect these associations.</p> </section> <section> <h3> Conclusions</h3> <p>The burden of pre-existing chronic conditions in pregnancy in Sweden increased from 2002 to 2019. This increase may be associated with the improved reporting of diagn
目的估计瑞典孕妇既往慢性病患病率的时间变化,并评估孕妇年龄、出生队列和肥胖的世俗变化与这些趋势的关联程度:设计:基于人口的横断面研究:背景:瑞典,2002-2019 年:所有在瑞典分娩的女性(15-49 岁)(2002-2019 年):方法:采用年龄-时期-队列分析法评估年龄、日历时期和出生队列对观察到的时间趋势的影响:产前慢性病,包括产前 5 年内记录的 17 种疾病类别的身体和精神健康状况,以患病率和比率比 (RR) 以及 95% 置信区间 (CI) 表示。时间趋势还根据孕前体重指数(BMI)和母亲的出生国进行了调整:至少一种孕前慢性病的总体患病率为 8.7%(1 703 731 名妇女中的 147 458 人)。从 2002-2006 年到 2016-2019 年,妊娠期原有慢性病的发病率增加了三倍(RR 2.82,95% CI 2.77-2.87)。精神疾病(RR 3.80,95% CI 3.71-3.89)、循环/代谢疾病(RR 1.62,95% CI 1.55-1.71)、自身免疫/神经疾病(RR 1.69,95% CI 1.61-1.78)和其他疾病(RR 2.10,95% CI 1.99-2.22)的发病率在 2002-2006 年至 2016-2019 年期间大幅上升。然而,在 2012-2015 年至 2016-2019 年期间,这些比率的增长并不明显。任何一种既往慢性病都没有明显的出生队列效应。对肥胖的世代变化和母亲的出生国进行调整也不会影响这些关联:结论:从2002年到2019年,瑞典妊娠期原有慢性疾病的负担有所增加。这一增长可能与妇女诊断报告的改善和慢性病治疗的进步有关,这可能会提高她们的生育能力。
{"title":"Changes in the prevalence of maternal chronic conditions during pregnancy: A nationwide age–period–cohort analysis","authors":"Louise Lundborg,&nbsp;Cande V. Ananth,&nbsp;K. S. Joseph,&nbsp;Sven Cnattingius,&nbsp;Neda Razaz","doi":"10.1111/1471-0528.17885","DOIUrl":"10.1111/1471-0528.17885","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To estimate temporal changes in the prevalence of pre-existing chronic conditions among pregnant women in Sweden and evaluate the extent to which secular changes in maternal age, birth cohorts and obesity are associated with these trends.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Population-based cross-sectional study.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Sweden, 2002–2019.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Population&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;All women (aged 15–49 years) who delivered in Sweden (2002–2019).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;An age–period–cohort analysis was used to evaluate the effects of age, calendar periods, and birth cohorts on the observed temporal trends.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main outcome measures&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Pre-existing chronic conditions, including 17 disease categories of physical and psychiatric health conditions recorded within 5 years before childbirth, presented as prevalence rates and rate ratios (RRs) with 95% confidence intervals (CIs). Temporal trends were also adjusted for pre-pregnancy body mass index (BMI) and the mother's country of birth.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The overall prevalence of at least one pre-existing chronic condition was 8.7% (147 458 of 1 703 731 women). The rates of pre-existing chronic conditions in pregnancy increased threefold between 2002–2006 and 2016–2019 (RR 2.82, 95% CI 2.77–2.87). Rates of psychiatric (RR 3.80, 95% CI 3.71–3.89), circulatory/metabolic (RR 1.62, 95% CI 1.55–1.71), autoimmune/neurological (RR 1.69, 95% CI 1.61–1.78) and other (RR 2.10, 95% CI 1.99–2.22) conditions increased substantially from 2002–2006 to 2016–2019. However, these increasing rates were less pronounced between 2012–2015 and 2016–2019. No birth cohort effect was evident for any of the pre-existing chronic conditions. Adjusting for secular changes in obesity and the mother's country of birth did not affect these associations.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusions&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;The burden of pre-existing chronic conditions in pregnancy in Sweden increased from 2002 to 2019. This increase may be associated with the improved reporting of diagn","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"132 1","pages":"44-52"},"PeriodicalIF":4.7,"publicationDate":"2024-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17885","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141428125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Placental biomarkers in the first trimester and adverse pregnancy outcome. 妊娠头三个月的胎盘生物标志物与不良妊娠结局。
IF 5.8 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-11 DOI: 10.1111/1471-0528.17868
Maryam Amjad
{"title":"Placental biomarkers in the first trimester and adverse pregnancy outcome.","authors":"Maryam Amjad","doi":"10.1111/1471-0528.17868","DOIUrl":"https://doi.org/10.1111/1471-0528.17868","url":null,"abstract":"","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2024-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141302077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal and neonatal outcomes among spontaneous vaginal births occurring in or out of water following intrapartum water immersion: The POOL cohort study 产前浸水后在水中或水外自然阴道分娩的产妇和新生儿结局:POOL 队列研究。
IF 4.7 1区 医学 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-10 DOI: 10.1111/1471-0528.17878
Julia Sanders, Christy Barlow, Peter Brocklehurst, Rebecca Cannings-John, Susan Channon, Judith Cutter, Billie Hunter, Mervi Jokinen, Fiona Lugg-Widger, Sarah Milosevic, Chris Gale, Rebecca Milton, Leah Morantz, Shantini Paranjothy, Rachel Plachcinski, Michael Robling
<div> <section> <h3> Objective</h3> <p>Warm water immersion during labour provides women with analgesia and comfort. This cohort study aimed to establish among women using intrapartum water immersion analgesia, without antenatal or intrapartum risk factors, whether waterbirth is as safe for them and their babies as leaving the water before birth.</p> </section> <section> <h3> Design</h3> <p>Cohort study with non-inferiority design.</p> </section> <section> <h3> Setting</h3> <p>Twenty-six UK NHS maternity services.</p> </section> <section> <h3> Sample</h3> <p>A total of 73 229 women without antenatal or intrapartum risk factors, using intrapartum water immersion, between 1 January 2015 and 30 June 2022. The analysis excluded 12 827 (17.5%) women who received obstetric or anaesthetic interventions before birth.</p> </section> <section> <h3> Methods</h3> <p>Non-inferiority analysis of retrospective and prospective data captured in NHS maternity and neonatal information systems.</p> </section> <section> <h3> Main outcome measures</h3> <p>Maternal primary outcome: obstetric anal sphincter injury (OASI) by parity; neonatal composite primary outcome: fetal or neonatal death, neonatal unit admission with respiratory support or administration of antibiotics within 48 hours of birth.</p> </section> <section> <h3> Results</h3> <p>Rates of the primary outcomes were no higher among waterbirths compared with births out of water: rates of OASI among nulliparous women (waterbirth: 730/15 176 [4.8%] versus births out of water: 641/12 210 [5.3%]; adjusted odds ratio [aOR] 0.97, one-sided 95% CI, −∞ to 1.08); rates of OASI among parous women (waterbirth: 269/24 451 [1.1%] versus births out of water 144/8565 [1.7%]; aOR 0.64, one-sided 95% CI −∞ to 0.78) and rates of the composite adverse outcome among babies (waterbirth 263/9868 [2.7%] versus births out of water 224/5078 [4.4%]; aOR 0.65, one-sided 95% CI −∞ to 0.79).</p> </section> <section> <h3> Conclusion</h3> <p>Among women using water immersion during labour, remaining in the pool and giving birth in water was not associated with an increase in the incidence of adverse primary maternal or neonatal outcomes.</p>
目的分娩过程中的温水浸泡可为产妇提供镇痛和舒适感。这项队列研究旨在确定在没有产前或产期风险因素的情况下使用产中浸水镇痛的产妇中,水中分娩是否与分娩前离开水中分娩一样对她们和婴儿安全:设计:队列研究,非劣效性设计:地点:英国国家医疗服务体系的 26 家产科服务机构:样本:2015 年 1 月 1 日至 2022 年 6 月 30 日期间,共有 73 229 名无产前或产中风险因素的产妇使用了产中浸水疗法。分析排除了 12 827 名(17.5%)在分娩前接受产科或麻醉干预的产妇:对国家医疗服务体系产科和新生儿信息系统中采集的回顾性和前瞻性数据进行非劣效性分析:孕产妇主要结局:产科肛门括约肌损伤(OASI)(按奇偶数统计);新生儿综合主要结局:胎儿或新生儿死亡、出生后48小时内因呼吸支持或使用抗生素而入住新生儿病房:结论:在使用水中分娩的产妇中,水中分娩的不良结局发生率(水中分娩:269/24 451 [1.1%]对非水中分娩:144/8565 [1.7%];aOR 0.64,单侧 95% CI -∞ to 0.78)和婴儿的综合不良结局发生率(水中分娩:263/9868 [2.7%]对非水中分娩:224/5078 [4.4%];aOR 0.65,单侧 95% CI -∞ to 0.79)均高于非水中分娩(水中分娩:269/24 451 [1.1%]对非水中分娩:144/8565 [1.7%];aOR 0.64,单侧 95% CI -∞ to 0.78):结论:在使用水中分娩的产妇中,留在水池中分娩与产妇或新生儿不良预后发生率的增加无关。
{"title":"Maternal and neonatal outcomes among spontaneous vaginal births occurring in or out of water following intrapartum water immersion: The POOL cohort study","authors":"Julia Sanders,&nbsp;Christy Barlow,&nbsp;Peter Brocklehurst,&nbsp;Rebecca Cannings-John,&nbsp;Susan Channon,&nbsp;Judith Cutter,&nbsp;Billie Hunter,&nbsp;Mervi Jokinen,&nbsp;Fiona Lugg-Widger,&nbsp;Sarah Milosevic,&nbsp;Chris Gale,&nbsp;Rebecca Milton,&nbsp;Leah Morantz,&nbsp;Shantini Paranjothy,&nbsp;Rachel Plachcinski,&nbsp;Michael Robling","doi":"10.1111/1471-0528.17878","DOIUrl":"10.1111/1471-0528.17878","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Objective&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Warm water immersion during labour provides women with analgesia and comfort. This cohort study aimed to establish among women using intrapartum water immersion analgesia, without antenatal or intrapartum risk factors, whether waterbirth is as safe for them and their babies as leaving the water before birth.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Design&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Cohort study with non-inferiority design.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Setting&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Twenty-six UK NHS maternity services.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Sample&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A total of 73 229 women without antenatal or intrapartum risk factors, using intrapartum water immersion, between 1 January 2015 and 30 June 2022. The analysis excluded 12 827 (17.5%) women who received obstetric or anaesthetic interventions before birth.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Methods&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Non-inferiority analysis of retrospective and prospective data captured in NHS maternity and neonatal information systems.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Main outcome measures&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Maternal primary outcome: obstetric anal sphincter injury (OASI) by parity; neonatal composite primary outcome: fetal or neonatal death, neonatal unit admission with respiratory support or administration of antibiotics within 48 hours of birth.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Rates of the primary outcomes were no higher among waterbirths compared with births out of water: rates of OASI among nulliparous women (waterbirth: 730/15 176 [4.8%] versus births out of water: 641/12 210 [5.3%]; adjusted odds ratio [aOR] 0.97, one-sided 95% CI, −∞ to 1.08); rates of OASI among parous women (waterbirth: 269/24 451 [1.1%] versus births out of water 144/8565 [1.7%]; aOR 0.64, one-sided 95% CI −∞ to 0.78) and rates of the composite adverse outcome among babies (waterbirth 263/9868 [2.7%] versus births out of water 224/5078 [4.4%]; aOR 0.65, one-sided 95% CI −∞ to 0.79).&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Conclusion&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Among women using water immersion during labour, remaining in the pool and giving birth in water was not associated with an increase in the incidence of adverse primary maternal or neonatal outcomes.&lt;/p&gt;\u0000","PeriodicalId":50729,"journal":{"name":"Bjog-An International Journal of Obstetrics and Gynaecology","volume":"131 12","pages":"1650-1659"},"PeriodicalIF":4.7,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1471-0528.17878","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141302075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Bjog-An International Journal of Obstetrics and Gynaecology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1